The author discusses the advantages and challenges of 'cellular phenotyping' and the way in which this integrated analysis of cellular phenotypes is likely to advance our understanding of the genetic and long-term environmental influences on complex traits.
The discovery of common and rare genetic variants underlying infectious disease susceptibility in humans highlights the involvement of shared host signalling pathways in diverse infectious diseases, and provides insights into the genetic control of immune signalling.
A large-scale analysis of SNPs and genes that are reported to be associated with common complex diseases and traits has found abundant pleiotropy: that is, each individual gene mutation may have a role in multiple diseases.
Exome sequencing is a powerful approach for accelerating the discovery of the genes underlying Mendelian disorders and, increasingly, of genes underlying complex traits. This Review describes the experimental and analytical options for applying exome sequencing and the key challenges in using this approach.
Locus-specific databases are the most useful repositories of the
sequence information underlying medical genetic conditions and, for this
reason, they need our continued support.
Genetic and genomic approaches — including high-throughput sequence analysis and transcriptomics experiments — are revealing a clearer picture of the pathophysiological steps underlying the different forms of heart failure (genetic and acquired) and the genomic responses to cardiac overload.
This Opinion article argues that capturing phase information in human genomics studies is crucial for important aims such as understanding how genotype contributes to phenotypes. existing approaches for phasing will need to be improved in order to meet this goal.
Individual human genomes are coming thick and fast, but they lack
information on the combination of alleles along single chromosomes — the
haplotype. Although common haplotypes can be identified using
statistical and family-based approaches, direct methods for readily
determining individual haplotypes would be extremely valuable for many
areas of research, from population genetics to pharmacogenomics.
Prediction of genetic values using whole-genome markers has been successfully applied in commercial breeding. This article outlines the use of this method for predicting health-related outcomes in humans.
G2P Knowledge Centre is part of GEN2PHEN and funded by the Health Thematic Area of the Cooperation Programme of the European Commission
within the VII Framework Programme for Research and Technological Development.